Cargando...
How will evolving future therapies and strategies change how we position the use of biologics in moderate to severely active inflammatory bowel disease
Several biologic agents have been added to our armamentarium of treatment options for moderate to severely active IBD, and this number is expected to only increase in the near future. With our growing understanding of disease mechanisms and pharmacokinetics, we are now able to target several mechani...
Gardado en:
| Publicado en: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5953904/ https://ncbi.nlm.nih.gov/pubmed/26835982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000661 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|